Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Christopher Capone currently holds 3,429 shares of MYRIAD GENETICS INC (MYGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Christopher Capone has been a net seller of MYGN stock. They have purchased $311.7K and sold $31.0M worth of shares.
Mark Christopher Capone's most recent insider trade was on Mar 10, 2026, when they purchased 1,301 shares at $76.35 per share.
Mark Christopher Capone serves as Executive at MYRIAD GENETICS INC (MYGN). They have executed 119 insider transactions totaling $31.3M over their tenure at the company.
Mark Christopher Capone holds the position of Executive at MYRIAD GENETICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Mark Christopher Capone has shown a selling trading pattern, with $311.7K in total purchases and $31.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Christopher Capone was on May 30, 2018, when they sold $3.4M worth of MYGN shares. This transaction involved 90,000 shares at $38.00 per share.
Mark Christopher Capone currently owns 3,429 shares of MYRIAD GENETICS INC (MYGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Christopher Capone's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Christopher Capone has 119 Form 4 filings on record as an insider at MYRIAD GENETICS INC.
Set alerts for Mark Christopher Capone and 40,000+ other insiders.